Getting in Balance: A Workplace Diabetes Prevention Intervention Trial

Inclusion Criteria: * Ethnicity: All ethnic groups; * Sex: all genders; * Age (as of date of enrollment): Lower age limit: 18 years; Upper age limit: NONE; * Body mass index ≥ 25.0 kg/m2; ≥23 kg/m2 if Asian * Having pre-diabetes based on a score of 9+ on the CDC pre-diabetes screener * Able and willing to enroll and provide written, informed consent, i.e., to: * meet the time and data collection requirements of the study; * be randomized to one of the two intervention programs; * adhere to the recommendations of the study intervention as assigned; and * participate in follow-up for 12 months. Exclusion Criteria: * Does not work at one of the participating employer work locations/departments; * Inability to speak, read, or understand English; * No regular access to a computer with internet capabilities; * Diagnosis of Type 1 or Type 2 diabetes mellitus; * Systolic blood pressure ≥ 180 mm Hg or diastolic blood pressure ≥ 100 mm Hg on more than one occasion during the last year; * Having a medical or physical condition that make moderate intensity physical activity (like a brisk walk) difficult or unsafe, such as exercise induced asthma or chronic obstructive pulmonary disease (COPD); * Use of weight-loss medications in the past 3 months; * Regular use (\> 5 days/month) of medications that affect appetite or weight (e.g., oral corticosteroids, insulin, oral hypoglycemics etc.); * Currently enrolled in a weight loss program; * Planning to undergo bariatric surgery during the study period; * Heart disease (angina, heart attack (myocardial infarction), congestive heart failure (CHF)), stroke; * Renal insufficiency; * Diagnosis of cancer (other than non-melanoma skin cancer) that was active or treated with radiation or chemotherapy within the past 2 years; * Pregnant, lactating or planning to become pregnant during the study period; * Already enrolled or planning to enroll in a research study that would limit full participation in this study or confound the observation and interpretation of the study's findings; * Planning to transfer to another department location during the study period; * Planning to move out of the area during the study period; * Investigator discretion for clinical safety or protocol adherence reasons.